BriaCell Therapeutics Corp.
BCTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001610820
No open-market purchases or sales by BriaCell Therapeutics Corp. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $1.58M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in BriaCell Therapeutics Corp. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- 0 vs. Q2 2022
- Shares held
- 2.53M
- −434.0K (−14.6%) vs. Q2 2022
- Total value
- $14.3M
- −$2.75M (−16.1%) vs. Q2 2022
- New holders
- 5
- 7 more added
- Sold out
- 5
- 6 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $1.58M |
| Q1 2026 | 16 | $1.62M |
| Q4 2025 | 13 | $69.2K |
| Q3 2025 | 13 | $136.5K |
| Q2 2025 | 16 | $181.1K |
| Q1 2025 | 14 | $94.1K |
| Q4 2024 | 26 | $379.1K |
| Q3 2024 | 22 | $538.1K |
| Q2 2024 | 20 | $452.0K |
| Q1 2024 | 20 | $6.38M |
| Q4 2023 | 26 | $14.6M |
| Q3 2023 | 21 | $17.0M |
| Q2 2023 | 21 | $17.9M |
| Q1 2023 | 21 | $19.4M |
| Q4 2022 | 21 | $12.3M |
| Q3 2022 | 22 | $14.3M |
| Q2 2022 | 22 | $17.0M |
| Q1 2022 | 18 | $33.5M |
| Q4 2021 | 20 | $10.9M |
| Q3 2021 | 21 | $4.77M |
| Q2 2021 | 24 | $20.3M |
| Q1 2021 | 10 | $1.45M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding BriaCell Therapeutics Corp.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 7 | $0 | 0.00% | −167−96.0% | Reduced |
| GHP Investment Advisors, Inc. | 33 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 32 | $0 | 0.00% | 00.0% | Unchanged |
| Covington Capital Management | 1 | $0 | 0.00% | +1 | New |
| Bank of America Corp | 500 | $3.00K | 0.00% | +500 | New |
| Cutler Group LP | 1,282 | $7.00K | 0.00% | +927+261.1% | Added |
| Parallax Volatility Advisers, L.P. | 2,016 | $11.0K | 0.00% | +2,016 | New |
| Tower Research Capital LLC (TRC) | 2,191 | $13.0K | 0.00% | −1,068−32.8% | Reduced |
| Morgan Stanley | 2,977 | $17.0K | 0.00% | +127+4.5% | Added |
| Bank of Montreal | 10,500 | $61.0K | 0.00% | +10,500 | New |
| Simplex Trading, LLC | 17,320 | $97.0K | 0.00% | +17,320 | New |
| Bluefin Capital Management, LLC | 17,546 | $99.0K | 0.01% | −3,150−15.2% | Reduced |
| Concord Wealth Partners | 17,775 | $100.0K | 0.03% | 00.0% | Unchanged |
| Apollon Wealth Management, LLC | 17,900 | $101.0K | 0.01% | +2,000+12.6% | Added |
| Summit Trail Advisors, LLC | 35,000 | $197.0K | 0.01% | 00.0% | Unchanged |
| Virtu Financial LLC | 48,347 | $272.0K | 0.02% | +37,894+362.5% | Added |
| Sabby Management, LLC | 94,005 | $528.0K | 1.14% | +36,416+63.2% | Added |
| Jane Street Group, LLC | 97,092 | $546.0K | 0.00% | +46,808+93.1% | Added |
| Redmond Asset Management, LLC | 137,689 | $774.0K | 0.29% | −253−0.2% | Reduced |
| Wasatch Advisors Inc | 353,744 | $1.99M | 0.01% | −2,754−0.8% | Reduced |
| K.J. Harrison & Partners Inc | 479,838 | $2.75M | 0.97% | −1,127,189−70.1% | Reduced |
| Lynwood Capital Management Inc. | 1,198,000 | $6.73M | 7.35% | +583,000+94.8% | Added |
| National Bank of Canada | 0 | $0 | 0.00% | −17,800−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −14,172−100.0% | Sold out |
| Total Clarity Wealth Management, Inc. | 0 | $0 | 0.00% | −3,185−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,672−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −76−100.0% | Sold out |